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Syntheses and properties of the new indole derivatives 18-33, 
being potential antiinflammatoric agents, are described. 1-p-Chlo-
robenzoyl-2-methyl-3-(2'-methyl-4'-nitroimidazol-1'-yl)-5-methoxy-
indole (32) have been found to possess pronounced antiinflammato-
ric activity and very low ulcerogenity. Attempting preparation of 
N-benzoylindole derivative 38 via sigmatropic rearrangement of the 
open chain precursor 35, as a model procedure for the new syn-
thesis of indomethacin, very low yields on the desired cyclic pro-
duct 38 have inevitably been obtained. 
INTRODUCTION 
Since some earlier reports1- 3 claimed strong antiinflammatory activity for 
1-(4-chlorobenzoyl)-2-methyl-5-methoxyindol-3-acetic acid (1, generic name: in-
domethacin), several groups have been exploring the field of polysubstituted 
N-acyl indoles, in order to find compounds with more beneficial therapeutic 
properties4•5, or to find a new synthetic approach to indomethacin6- 7. In this 
paper we describe our own efforts directed toward both these aims. 
RESULTS AND DISCUSSION 
Two entirely different synthetic approaches to N-benzoylated-2-methyl-3,5-
-disubstituted indoles have been investigated during the course of this work. 
The first was based on the classical Fischer-indole synthesis8• Introduction of 
the substituted-benzoyl group on N(l) was attempted at early stages of the 
synthesis, since some steps in the preparation of unacylated indoles gave low 
yields of the desired product, but several undesired side-products. Seemingly, 
the most attractive pathway was p-chlorobenzoylation of N(l)-(4-methoxyphe-
nyl)-N(2)-t-butyl-levulinate hydrazone (2), which was prepared by a procedure 
used by Stevens et al.9 in preparing a similar compound. Extensive experiment-
ation, however, failed to show a way for N(l)-p-chlorobenzoylation10 of this 
compound. Attempted mono-condensation of B-diketones with p-methoxyphenyl-
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Thereafter we turned to using benzaldehyde as . a protecting group, and 
the p-methoxyphenylhydrazone thus obtained11 was p-chlorobenzoylated into 5. 
Among other spectroscopic and analytical supports for structure 5, there was 
a hypsochromic shift of the two characteristic UV-bands at 352 and 320 nm, 
respectively, due to N(l)-benzoylation so that the benzoylated product posse-
ssed bands at 299 and 275 nm, respectively. The hydrolytic cleavage of the 
protecting group in 5 proved to be very cumbersome and lead to concomitant 
cleavage of the acyl group. Therefore we went over to acetaldehyde7 as the 
protecting group, which allowed high yields of the N(l)-acyl-N(2)-hydrazones 
6-11, and their selective cleavage leading to hydrochlorides 12-17. Most of 
these could be subsequently cyclized with B-diketones in glac. acetic acid, 
giving 1,3-diaroyl indoles 18-27. Under similar cyclization conditions, indoles 
with various C(3)-substituents, 28-33, have also been prepared. 
Pharmacological screening of compounds 18-33 gave results showing that 
compound 32 compared most favorably with indomethacin in regard to analgetic 
power and low ulcerogenic activity13• 
TABLE I 




















• Fifty-per cent lethal doses (LDoo, mg/k g): 32 : > 1000, indomethacin : 30, phenylbutazone : 1120. 
• Relative analgetic activity was determined on groups of 6-10 male albino rats tested for respon-
siveness to pressure applied to a fix ed point upon the noninflamed plantar surface of the foot. 
The experimental p rocedure followed w as entirely those described by Randall and Selitto" . 
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TABLE II 























a Experimental method described in : G . Vo 1 terr a, N. Pis anti, and A. Me 1 i , P r oc. 




It is worth mentioning that high antiinflammatory aCtivity found with 32, 
when applying standard tests, is not connected with the presence of a-(hetero)-
-aryl acetic-, or propionic moiety, which are usually present in antiinflammatory 
substances4•14 . The absence of such groups may account for the very low 
ulcerogenic activity of 32, which is the most frequent side effect of other acidic 
antiinflammatory agents. 
A completely different route to indomethacin was envisaged in preparation 
of compound 34, and its cyclization accompanied by thermal 1,7-sigmatropic 








Therefore, model cyclization reactions of 35 and 36 were investigated. We 
regarded the polar imide structures of these compounds both of which carry 
positive charges on the nitrogen atoms as being equivalent to protonated, or to 
Lewis-acid coordinated, alkyl anilines in the charge-induced sigmatropic rear-
rangements intensively studied by H. Schmid et al.15,16. 
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SCHEME 1. 
Of the two heterocycles presumed to form as the products of pathways 
A and B, only compound 38 has been isolated at a rather low yield. The product 
of pathway B was not isolated, although its formation was expected because 
similar products of cyclization were obtained with some sec.-propargyl amidesn. 
Under more forcing conditions15•16 simultaneous formation of 37 was observed. 
The latter can be formally regarded as the addition product of one mole of 
water to the triple bond in 35. 
Relating to the observation of Schmid et al.16 that allyl-derivatives are 
generally more reactive than propargyl-derivatives in the charge-induced Clai-
sen- and amino-Claisen rearrangements, we tried to cyclize 36 in sulfolane. In 
some experiments we introduced oxygen to oxidize the presumably formed 
2,3-dihydro intermediary derivative of 38. However, all attempts led to untrac-
table mixtures of compounds, where N-debenzoylated products prevailed. Thus, 
we were forced to conclude that charge polarization in the tert.-amides 35 and 
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36 behaves not so activating by far as full-charge introduction in proton- or 
Lewis-acid catalysed amino-Claisen rearrangements16. 
EXPERIMENTAL 
Melting points were determined on a Kofler-microheating stage and are uncorre-
cted. NMR-spectra were obtained on spectrometers Varian T-60 and Perkin Elmer 
R 12A, using TMS as an internal standard; shifts are given as .5 values in ppm. 
IR spectra were recorded on a Perkin Elmer M-257 spectrophotometer and are for 
KBr-pellets, unless stated otherwise. UV spectra were obtained on a Varian-Techtron 
UV-VIS M-635 automatic spectrophotometer. Column chromatography was run on 
silicagel 0.05-0.2 mm (Merck), fractions were collected automatically using a LKB 
7000 Ultra Rae instrument, and monitored by TLC on silicagel F-254 plates (Merck), 
using an UV-254 nm lamp. 
Starting materials. - p-Chloro- and p-methoxyphenylhydrazines18 and their 
corresponding acetaldehydhydrazones7, and p-methoxyphenylhydrazone of tert.-butyl 
levulinate (2)9 were prepared according to literature directions. All hydrazones 
exhibited characteristic IR bands at 3310-3350 (Ar-NH), 1630-1640 (C=N), 1345-1350 
cm-1 (Ar-N); NMR-spectra of acetaldehyde-hydrazones contained characteristic 
doublets at 1.88 ppm (-CH3) and quartets at 6.85 ppm (-CH=N). 
1-(p-Chlorophenyl)-5-(p-methoxyphenyl)-3-methylpyrazol (3) 
The Na-salt of p-chlorophenylhydrazine sulfonic acid (5.0 g, 20 mmol) was 
slurried in 900/o ethanol (25 ml), cone. hydrochloric acid (1.6 ml, 20 mmol) was added, 
and the whole was heated under reflux for 15 min. To the hot ' solution sodium 
acetate (2.8 g, 21 mmol) dissolved in water (5 ml) and p-methoxybenzoylacetone 
(3.5 g, 18 mmol) were added. After a brief period of heating under reflux, the reaction 
mixture was allowed to cool slowly, and upon reaching ambient temperature was 
poured into ice-cold water (150 ml). The aqueous layer was decanted from the 
yellow oily product, and the latter was repeatedly washed with water. Crude 3 
crystallized slowly on standing in dessicator. Recrystallization from ethanol, with 
addition of charcoal, gave 3.2 g (600/o) of 3, m. p. 103-105 {)C. NMR (CDC13) 2.35 (s, 
3H), 3.75 (s, 3H), 6.23 (s, lH), 6.97 (dd, 4H), 7.24 (dd, 4H) . 
Anal. for C11H15ClN20 (298.76) calc'd.: C 68.34; H 5.06; N 9.380/o 
found: C 68.17; H 4.87; N 9.090/o 
1-(p-Chlorophenyl)-5-(p-bromophenyl)-3-methylpyrazol ( 4) 
Starting from the Na-salt of p-chlorophenylhydrazine sulfonic acid (5.0 g, 20 
mmol), a free base was prepared as described for 3. All attempts to condense it 
with p-bromobenzoylacetone led to cyclization into 4. Working under tP.e same 
reaction conditions as described for 3, compound 4 was isolated in 580/i. yield, m. p. 
133-135 °c (from ethanol). NMR (CDC13) 2,38 (s, 3H), 6.33 (s, lH), 6,7-7.3 (m, 8H). 
Anal. for C1aH12BrClN2 (347.64) calc'd.: C 55.28; H 3.48; N 8.050/o 
found: C 54.91; H 3.22; N 8.170/o 
N(l)-(p-Methoxyphenyl)-N(l)-(p-chlorobenzoyl)-N(2)-benzaldehyde 
hydrazone (5) 
Benzaldehyde p-methoxyphenylhydrazone (0.70 g, 3.0 mmol) was dissolved in 
a mixture of aqueous sodium hydroxyde (10 ml, 6.0 mmol NaOH) and dioxane (3.0 
ml) by gradual addition with ice-cooling and stirring. To the resulting solution 
p-chlorobenzoylchloride (1.0 g, 6,0 mmol) was added dropwise over a period of 0.5 
h. During this period the crude product crystallized and was separated by suction 
(1.2 g). On recrystallization from benzene-light petroleum (40-60 °C), pure 5 was 
obtained (0.8 g, 800/o yield), m. p. 156-158 °c. NMR (CDC13) 3.84 (s, 3H), 6.98 (s, lH), 
7.22 (dd, 4H), 7.39 (s, 5H), 7.62 (dd, 4H). 
Anal. for C21H17ClN202 (364.82) calc'd.: C 69.14; H 4.70; N 7.680/o 
found: C 68.92; H 4,87; N 7.500/o 
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GeneraL procedure for preparation of N(l)-p-substituted-phenyL-N(l)-
-acyL-N-(2)-acetaLdehyde hydrazones 6-11 
p-Substituted phenylhydrazones of acetaldehyde (30 mmol) were dissolved in 
dry pyridine (20 ml), and the solution was cooled in ice. Substituted benzoylchlorides 
(38 mmol) were added dropwise with cooling and stirring over ·a period of 1 h. After 
an additional 4 h stirring at ambient temperature, the pasty reaction mixture was 
diluted with ice-water (150 ml). After standing overnight in an ice box, the crude 
products crystallized, and were collected on a filter by suction. After having been 
thoroughly washed with water, the solids were dried in a dessicator over cone. 
sulfuric acid. When the crude products had separated as oils, the aqueous layer was 
decanted, the oils were washed with water and dried. 
All compounds exhibit characteristic IR amide bands at 1660-1670 cm-1, while 
in NMR spectra no change in the position of the acetaldehydic protons (d, 1.85 ppm, 
q, 6.8 ppm) was detected. Yields and m. p.'s are given in Table III. These products 
have been used in the next steps without purification, since they turned out to be 



































GeneraL procedure for preparation of N(l)-p-substituted-phenyL-N(l)-
-acyLhydrazine hydrochLorides 12-17 
Slurries of crude N(l)-p-substituted-phenyl-N(l)-acyl-N(2)-acetaldehyde hydra-
zones (30 mmol) were preparated with a solvent mixture of toluene (100 ml) and abs. 
methanol (5.0 ml), and were cooled in an ice-bath with continuous stirring. Dry 
hydrogen chloride (3-4 g) was bubbled through the mixtures during 1 h . After an 
additional 15 min stirring at 0 °c, the reaction flask was connected to a water pump 
and excess hydrogen chloride was remowed in vacuo. A crystalline solid separated; 
and was filtered off with suction, washed with benzene ahd ether, and dried in 
vacuo. NMR spectra (CD30D) lacked the characteristic signals for a CH3CH = N-
group, but IR spectra contained characteristic amide bands at 1615-1620 cm-1. Other 
characteristic constants are presented in Table IV. 
GeneraL procedure for preparation of N(l)-acyLated-2-methyL-3,5-
-disubstituted indoLes 18-27 
.N(l)-p-substituted-phenyl-N(l)-acylhydrazine hydrochlor ides (10 mmol) and 
~-dicarbonyl compounds were dissolved in glac. acetic acid (30 ml) and heated at 









u Lit. 7 : m .p. rns-112 •c. 
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'rABLE IV 
R2 m. p,/°C 
4-Cl-C6H4- 164-166" (decc.) 
3,S-diN02-C6H4- 182-104 (decc.) 
4-Cl-CsH4- 161-163 (decc.) 
phthalimido- 14S-148 (decc.) 
glycyl 
4-Cl-C:sH4- 170-173 (decc.) 










compounds 23 and 24 crystallized after chilling the filtrate. In all other instances 
the solvent was evaporated in vacuo, and traces of acetic acid removed by repeated' 
evaporation with benzene. The remaining crude products were recrystallized from 
the solvents indicated in Table V. 
Compound 21 crystallized in two different forms, one having m . p. 107-109 °c 
(from light petroleum, pale-yellow crystals) , and the other 127-128 ~c (from ethyl-
acetate-light petroleum, colourless crystals). Their IR spectra in solution (CHC13) , 
as well as NMR spectra (CDC13) were identical, while IR spectra of KBr-disks exhibited 
significant difference in the finger-print region. Attempted thermo-microanalysis 
of the three mixtures (1 : 3, 1 : 1 and 3 : 1), on the Kofler-microheating stage, failed 
to give u seful results. All mixtures melted at 12S-128 °C indicating a transformation 
of the lower-melting into the higher-melting form w hile being ground in the mortar. 
The polysubstituted indoles listed in Table V exhibited following NMR spectra 
(solvent, c5): 
18 (acetone-d6) 2.32 (s, 3H), 3.64 (s, 3H), 6.6-7.1 (m, 3H), 7.4-7.9 (m, 9H) . 
19 (CDC13) 2.43 (s , 3H), 3.74 (s, 3H), 3.91 (s , 3H), 6.6-7.1 (m, 3H), 7.4-8.0 (m, 8H). 
20 (DMF-d7) 2.36 (s , 9H ; 3 X CH3), 3.73 (s, 3H), 6.7-8.1 (m , lOH) . 
21 (CDC13) 2.32 (s, 3H), 3.71 (s, 3H), 3.90 (s, 3H), 6.6-7.2 (m, SH), 7.S-8.0 (m, 6H). 
22 (DMF-d7) 2.29 (s, 3H), 3.73 (s, 3H), 3.76 (s, 3H), 3.89 (s, 3H), 6.6-8.0 (m, lOH) . 
23 (acetone-d6) 2.30 (s, 3H), 3.6S (s, 3H), 6.6-7.l (m, 3H), 7.4-8.0 (m, 8H). 
24 (DMF-d7) 2.32 (s, 3H), 3.73 (s, 3H), 6.S-7.2 (m, SH), 7.6-8.1 (m, 6H). 
25 (DMF-d7) 2.3S (s, 3H), 3.68 (s, 3H), 6.7-8.6 (m, 14H). 
26 (acetone-d6) 2.32 (s, 3H), 3.6S (s, 3H), 3.91 (s, 3H), 6.6-7.1 (m, 3H), 7.4-8.0 (m, 8H). 
27 (DMF-d7) 2.38 (s , 3H), 3.67 (s , 3H), 3.96 (s, 3H), 6.7-8.S (m, 14H). 
28 (DMF-d7) 2.32 (s , 3H), 3.70-3.8S (m, 2H), 3.78 (s, 3H), 3.88 (s, 3H), 6.6-7.8 (m, 8H). 
29 (DMF-d7) 2.32 (s, 3H), 3.7-3.9 (m, 2H), 3.84 (s, 3H), 6.7-7.3 (m, 3H), 9 . 0-9.3 (m, 3H). 
1-p-Chloro b enzoy l-2 ,3-dimeth y l-5-chloroindole (30) 
N(l)-p-Chlorophenyl-N(l)-p-chlorobenzoylhydrazine hydrochloride (1.6 g, S.0 
mmol) in 6.0 ml of m ethyl- ethylketone was heated under reflux for 3 h . Excess 
ketone was evaporated in vacuo and the residue was crystallized from aqueous 
acetone. Pure 30, 1.27 g (80% ), yellow crystals had am. p. 128- 130 °c. NMR (DMSO-d6) 
2.20 (s, 6H ; 2 X CHa), 7.1--7.7 (m, 7H). 
Anal. for CliH13Cl2NO (318.18) calc'd.: C 64.16; H 4.11 ; N 4.40°/u 
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1-p-Chlorobenzoyl-2 ,3-dimethyl-5-methoxyindole (31) 
Starting from N(l)-p-methoxyphenyl-N(l)-p-chlorobenzoylhydrazine hydrochlo-
ride (1.6 g, 5.0 mmol) and 6.0 ml of methyl-ethylketone, crude 3,1 was prepared in 
the same manner as described for 30. On recrystalll.zation from 700/o ethanol, 1.17 g 
(75%) of 31 with m. p. 81-83 °c was obtained (lit. 21: m. p. 93-94 °C). NMR (DMSO-d6) 
2.21 (s, 6H; 2 X CH3), 3.75 (s, 3H), 7.2-7.8 (m, 7H). 
Anal. for C1sH16ClN02 (313.77) calc'd .: C 68.90; H 5.14; N 4.460/o 
found: C 69.11; H 5.33; N 4.28-0/o 
1-p-Chloro b enzoy l-2-meth y l-3-(2' -meth y l-4' -nitroimidazol-1 '-y l)-
-5-methoxyindole (32) 
N(l)-p-Methoxyphenyl-N(l)-p-chlorobenzoylhydrazine hydrochloride (3.2 g, 10.0 
mmol) and 1-(2'-oxopropyl)-2-methyl-4-nitroimidazole22 (1.8 g, 10.0 mmol) were dissol-
ved in glac. acetic acid (20 ml) and heated at 90-100 °c for 8 h. An inorganic preci-
pitate was filtered off, and the filtrate was chilled on ice, giving 1.83 g (430/o) of 
crystalline 32 which, on recrystallization from aqueous acetone, melted at 224-226 °c. 
IR (KBr) 1690, 1590, 1540, 1495, 1465, 1255, llSO, 765 cm-1. NMR (CDC13) 2.21 (s, 6H; 
2 X CH3), 3.92 (s, 3H), 3.99 (s, 3H), 6.62 (q, lH), 6.S-7.3 (m, 4H), 7.75 (s, lH), 7.8S (s, 2H). 
Anal. for C21H11ClN404 (424.S3) calc'd.: C 59.37; H 4.030/o 
found: C 59.14; H 4.240/o 
1-p-M ethoxy benzoy l-3-meth y l-3-(2' -me thy l-4' -nitroimidazo l-1 '-y l)-
-5-methoxyindole (33) 
Compound 33 was prepared by starting from N(l)-p-methoxyphenyl-N(l)-p-
-methoxybenzoylhydrazine hydrochloride (2.15 g, 7.0 mmol), using the same reaction 
conditions as described for 32. The crude product (1.5 g) was purified by recrystalli-
zation from methylene chloride - light petroleum. Yield 1.2 g (400/o), m. p. 227-229 °c. 
IR (KBr) 1700, 1610, 1590, 1540, 1500, 1465, 1310 cm-1. NMR (DMF-d7) 2.28 (s, 6H; 
2 X CH3), 3.73 (s, 3H), 3.SS (s, 3H), 6.5-7.S (m, SH). 
Anal. for C22H2oN405 (420.41) calc'd. : C 62.S5; H 4.790/o 
found: C 62.91 ; H 4.S40/o 
N-Propargyl-N-( 4'-chlorobenzoyl)-4-methoxyaniline (35) 
N-(4 '-Chlorobenzoyl)-4-methoxyaniline (m. p. 207-20S 0c 12.2 g, 46.6 mmol) was 
alkylated with propargyl bromide (10.0 g, 84.1 mmol) in DMF (150 ml), in 
the presence of barium oxyde (10.0 g). After stirring for 24 h at room temperature, 
cellite (»filter aid«, 2-3 g) was added, and the inorganic precipitate was filtered off. 
The filtrate was evaporated to dryness at 50 °c in vacuo, the residual oil was emul-
sified with water (200 ml) and extracted with ether (3 X 100 ml). After drying 
(Na2S04) ethereal extracts were evaporated, and residual crude 35 was crystallized 
from diisopropylether, giving S.46 g (60.5°/o) of pure substances with m. p. Sl-S2 °c. 
NMR (CDC13) 2.23 (t, lH), 3.73 (s, 3H), 4.60 (d, 2H) , 6.7-7.5 (m, SH). 
Anal. for C17H 14ClN20 (299.76) calcl'd.: C 6S.12 ; H ·PO; N 4.67a/o 
found: C 67.90; H 4.86; N 4.S3°/o 
N-Allyl -N-( 4' -chlorobenzoyl)-4-methoxyaniline (36) 
Starting from N-(4'-chlorobenzoyl)-4-methoxyaniline (5.5 g, 21.S mmol), allyl-
iodide (5.0 g, 30.0 mmol) and barium oxyde (5.0 g) in DMF (SO ml), compound 36 
was prepared by using the same manner as described for 35. After extracting the 
crude product into ether, drying and evaporation, the residue was distilled at 
lS0-185 °C/0.03 mm Hg, to give pure oily 36 (5.6 g, S50/o). This oil crystallized after 
lengthy standing on ice; m. p. 29-32 °c. NMR (CDCla) 3.67 (s, 3H), 4.37 (d, 2H), 4.9-5.3 
(m, 2H), 5.6-6.1 (m, lH) , 6.6-7.2 (m, SH). 
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Anal. for C17H16ClN20 (301.78) calc'd.: C 67.67; H 5.34; N 4.640/o 
found: C 67.48; H 5.48; N 4.390/o 
CycLization of the compound (35) 
91 
Compound 35 (2.89 g, 9.66 mmol) was dissolved in sulfolane (50 ml, dried before 
use by distillation over KOH-pellets, bp 110-112 °C/0.03 mm Hg), and heated at 230 °C 
by using a Wood's metal bath. The reaction was conducted in an atmosphere of 
carefully dried nitrogen, and monitored by TLC chloroform-light petroleum (95 : 5) 
as the eluant. After heating for 18 h , the sulfolane was evaporated at 0.2 mm Hg, 
the residue was emulsified with 100 ml of water and extracted into ether (3 X 50 
ml). The ethereal extracts were washed with brine (3 X 50 ml), dried and evaporated. 
The resulting mixture was fractionated on a silicagel column (90 g), using chloroform 
as the eluant; 5-ml fractions were collected. The fractional distribution was as 
follows 120-125, pure 38 (53 mg); 126-159, unreacted 35 (798 mg); 163-167, N-(4'-
-chlorobenzoyl)-4-methoxyaniline (i.e. dealkylated 35, 125 mg); 168-176, a mixture 
of dealkylated 35 and 37 (860 mg) ; 177-182, pure 37 (388 mg). 
1-( 4' -Chlorobenzoyl)-2-methyl-5-methoxyindole (38) 
Compound 38, obtained from fractions 120-125, exhibited the following signals 
in the NMR spectrum (CDC13): 2.38 (s, 3H), 3.80 (s, 3H), 6.35 (s, lH), 6.5-7.7 (m, 7H). 
On recrystallization from methanol it melted at 60-63 °c. 
An authentic sample of 38 was prepared from 2-methyl-5-methoxyindole (2.3 g, 
14.2 mmol, prepared according to ref. 23 but with 35.60/o yield, in contrast to 1°/o 
claimed by the original authors), which was converted into the Na-salt by dissolving 
in DMF (80 ml) and gradually adding sodium hydride (1.0 g, 20 mmol, as a 500/o 
suspension in mineral oil). After 0.5 h stirring at ambient temperature, the resulting 
solution was ice-cooled, and p-chlorobenzoylchloride (2.4 ml, 18 mmol) was added 
dropwise. Stirring at 0 °C was continued for 8 h , then the reaction mixture was poured 
into 250 ml of water containing 2.5 ml of acetic acid. The product was extracted with 
ether (3 X 50 ml), then with benzene (2 X 50 ml). The combined extracts were w ashed 
with satd. aqueous sodium bicarbonate, dried, evaporated and crude 38 crystallized 
from methanol giving 3.2 g (76.20/o), mp. 63--65 °c. 
Anal. for C17H 14ClN02 (299.75) calc'd.: C 68.11; H 4.71 ; N 4.670/o 
found: C 67.87; H 4.92; N 4.940/o 
N-(2' -Oxopropyl)-N-( 4'-chlorobenzoyl)-4-methoxyaniline (37) 
The product isolated from fractions 177-182 (see above) was recrystallized from 
diisopropylether, m . p. 96-98 °c. IR (KBr) 3010, 2980, 1730, 1645, 1588, 1510, 1405, 1372, 
1243, 1222, 1086, 1010, 842, 836 and 755 cm-1. NMR (CDC13) 2.33 (s, 3H), 3.77 (s, 3H), 4.63 
(s, 2H), 6.6-7.6 (m, 8H). · 
Anal. for C17H 16ClN03 (317.77) calc'd .: C 64.25; H 5.08 ; N 4.420/o 
found: C 64.57 ; H 5.12; N 4.680/o. 
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SAZETAK 
Sinteze novih derivata indola slicnih indometacinu 
M. Mihalic, v. Sunjic, F . Kajfez, v. Caplar i T. Kovac 
Opisane su priprave i svojstva novih derivata indola 18-33, kao potencijalnih 
antiinflamatornih sredstava. 1-p-Klorbenzoil-2-metil-3-(2'metil-4'-nitroimidazol-1'-il)-
-5-metoksiindol (32) pokazao je izrazito antiinflamatorno djelovanje uz vrlo nisku 
ulcerogenost. PokusavajuCi pripravu N-benzoil-indolskog derivata 38 sigmatropnom 
pregradnjom lancastog prekursora 35, sto je bio modelni postupak za novu sintezu 
indometacina, redovito su postignuta niska iskoristenja foljenoga ciklickog pro-
dukta 38. 
ODJEL ZA BIOMEDICINSKA I BIOKEMIJSKA ISTRAZIV ANJA 
COMPAGNIA DI RICERCA CHIMICA, CR C, 
33048 SAN GIOVANNI AL NATISONE (UD) , ITALIJA 
Prispjelo 24 . sijecnja 1977. 
